Phase II Trial of CoQ10 for ALS Finds Insufficient Evidence to Justify Phase III
Annals of Neurology - United States
doi 10.1002/ana.21743
Full Text
Open PDFAbstract
Available in full text
Categories
Date
August 1, 2009
Authors
Publisher
Wiley
Available in full text
August 1, 2009
Wiley